You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Hepatorenal syndrome: the 8th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group
|
|---|---|
| Published in |
Critical Care, February 2012
|
| DOI | 10.1186/cc11188 |
| Pubmed ID | |
| Authors |
Mitra K Nadim, John A Kellum, Andrew Davenport, Florence Wong, Connie Davis, Neesh Pannu, Ashita Tolwani, Rinaldo Bellomo, Yuri S Genyk |
| Abstract |
Renal dysfunction is a common complication in patients with end-stage cirrhosis. Since the original publication of the definition and diagnostic criteria for the hepatorenal syndrome (HRS), there have been major advances in our understanding of its pathogenesis. The prognosis of patients with cirrhosis who develop HRS remains poor, with a median survival without liver transplantation of less than six months. However, a number of pharmacological and other therapeutic strategies have now become available which offer the ability to prevent or treat renal dysfunction more effectively in this setting. Accordingly, we sought to review the available evidence, make recommendations and delineate key questions for future studies. |
Mendeley readers
The data shown below were compiled from readership statistics for 220 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | <1% |
| France | 2 | <1% |
| Colombia | 1 | <1% |
| Brazil | 1 | <1% |
| United Kingdom | 1 | <1% |
| Germany | 1 | <1% |
| Russia | 1 | <1% |
| Mexico | 1 | <1% |
| Greece | 1 | <1% |
| Other | 1 | <1% |
| Unknown | 208 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Postgraduate | 39 | 18% |
| Other | 25 | 11% |
| Researcher | 23 | 10% |
| Professor > Associate Professor | 21 | 10% |
| Student > Master | 18 | 8% |
| Other | 56 | 25% |
| Unknown | 38 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 158 | 72% |
| Agricultural and Biological Sciences | 5 | 2% |
| Nursing and Health Professions | 5 | 2% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 1% |
| Arts and Humanities | 2 | <1% |
| Other | 9 | 4% |
| Unknown | 38 | 17% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 July 2016.
All research outputs
#8,534,528
of 25,373,627 outputs
Outputs from Critical Care
#4,396
of 6,554 outputs
Outputs of similar age
#74,973
of 254,230 outputs
Outputs of similar age from Critical Care
#46
of 128 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,554 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.8. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 254,230 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 128 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.